Drug Type Small molecule drug |
Synonyms L-159463 |
Target |
Action inhibitors |
Mechanism LpxC inhibitors(UDP-3-O-acyl-N-acetylglucosamine deacetylase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Bacterial Infections | Preclinical | United States | 08 Nov 1996 |





